• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results

    5/22/24 2:32:03 PM ET
    $AKTS
    $BDRX
    $BNED
    $EDBL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Wednesday.

    The Dow traded down 0.71% to 39,588.89 while the NASDAQ fell 0.66% to 16,721.24. The S&P 500 also fell, dropping, 0.62% to 5,288.55.

    Check This Out: Top 5 Industrials Stocks That May Explode This Quarter

    Leading and Lagging Sectors

    Health care shares rose by 0.2% on Wednesday.

    In trading on Wednesday, energy shares fell by 2%.

    Top Headline

    The TJX Companies, Inc. (NYSE:TJX) reported better-than-expected first-quarter financial results on Wednesday.

    The company reported first-quarter FY25 sales growth of 5.9% year-on-year to $12.479 billion, beating the analyst consensus estimate of $12.463 billion. Overall comp store sales increased 3%. EPS of 93 cents beat the consensus estimate of 87 cents.

    The company expects FY25 EPS of $4.03-$4.09 (up from $3.94-$4.02)

    Equities Trading UP
                           

    • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares shot up 127% to $0.3120 after the company reportedly floated the probability of bankruptcy after losing a lawsuit against Qorvo.
    • Shares of Barnes & Noble Education, Inc. (NYSE:BNED) got a boost, surging 96% to $1.0590 on continued volatility. Greenhaven last week said it continues to explore a possible transaction with the company.
    • Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) shares were also up, gaining 23% to $3.0150 following better-than-expected quarterly financial results.

    Equities Trading DOWN

    • Edible Garden AG Incorporated (NASDAQ:EDBL) shares dropped 49% to $2.23 after the company announced the pricing of a $6 million public offering.
    • Shares of Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) were down 42% to $1.36 after the company announced $7 million of gross proceeds from warrant exercises.
    • Oragenics, Inc. (NYSE:OGEN) was down, falling 37% to $1.9124. Oragenics named William “Frank” Peacock MD as Chief Clinical Officer.

    Also Check This Out: Qualcomm, American Express And 2 Other Stocks Insiders Are Selling

    Commodities

    In commodity news, oil traded down 1% to $77.85 while gold traded down 1.4% at $2,392.20.

    Silver traded down 2% to $31.445 on Wednesday, while copper fell 5.1% to $4.8440.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.34%, Germany's DAX fell 0.25% and France's CAC 40 dipped 0.61%. Spain's IBEX 35 Index fell 0.05%, while London's FTSE 100 fell 0.55%.

    The annual inflation rate in the UK fell to 2.3% in April from 3.2% in March, while producer prices rose 1.1% year-over-year in April.

    Passenger car registrations in the European Union jumped 13.7% year-over-year to 914 thousand units in April.

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.85%, China's Composite Index gaining 0.02%, Hong Kong's Hang Seng Index falling 0.13% and India's S&P BSE Sensex gaining 0.2%.

    Japanese trade deficit rose to JPY 462,50 billion in April compared to a year-ago gap of JPY 429,79 billion. Japan’s core machinery orders climbed 2.9% month-over-month to 913 billion yen in March.

    Economics

    U.S. mortgage applications rose by 1.9% from the prior week in the period ending May 17, compared to a 0.5% gain in the prior week.

    U.S. existing home sales fell 1.9% month-over-month to an annualized rate of 4.14 million units in April versus a revised 4.22 million in the prior month.

    U.S. crude oil inventories climbed by 1.825 million barrels in the week ending May 17, compared to a 2.508 million decline in the prior period, the EIA said. However, analysts were expecting a 2.55 million barrel decline.

    Now Read This: Jim Cramer: This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $BDRX
    $BNED
    $EDBL

    CompanyDatePrice TargetRatingAnalyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    TJX Companies Inc.
    $TJX
    1/8/2026Buy
    Deutsche Bank
    TJX Companies Inc.
    $TJX
    12/10/2025$175.00Buy
    Guggenheim
    TJX Companies Inc.
    $TJX
    11/20/2025$155.00 → $170.00Outperform
    Telsey Advisory Group
    TJX Companies Inc.
    $TJX
    10/15/2025$165.00Buy
    BTIG Research
    More analyst ratings

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Anderson Joel D was granted 5,000 shares, increasing direct ownership by 0.15% to 3,231,281 units (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/3/26 7:07:21 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Director Lane Amy B gifted 174 shares and bought $7,915 worth of shares (116 units at $68.23), decreasing direct ownership by 3% to 29,007 units (SEC Form 4)

    4 - TJX COMPANIES INC /DE/ (0000109198) (Issuer)

    2/3/26 7:00:03 PM ET
    $TJX
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: Director Telling Fred sold $198 worth of shares (210 units at $0.94), decreasing direct ownership by 18% to 948 units (SEC Form 4)

    4/A - ORAGENICS INC (0001174940) (Issuer)

    1/22/26 1:04:30 PM ET
    $OGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $EDBL
    SEC Filings

    View All

    Edible Garden AG Incorporated filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Edible Garden AG Inc (0001809750) (Filer)

    2/5/26 7:30:46 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 424B3 filed by Biodexa Pharmaceuticals plc American Depositary Shs

    424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)

    2/4/26 8:51:45 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Biodexa Pharmaceuticals plc American Depositary Shs

    424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)

    2/4/26 8:51:26 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edible Garden to Participate in ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026

    BELVIDERE, NJ, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, taking place February 10–12, 2026, at the Hyatt Regency Chicago O'Hare in Rosemont, Illinois. ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session brings together leading brands and top retail buyers through curated, one-on-one meetings designed to drive meaningful product discovery and comme

    2/5/26 8:09:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

    February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models Cardiff, UK – February 4, 2026 – Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today announced the closing of an exclusive license with Otsuka Pharmaceutical Co., Ltd (Otsuka) for OPB-171775. a novel molecular glue intended to be developed for the treatment of gastrointestinal stromal tumours (GIST). The compound also has the potential to be useful

    2/4/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lane Amy B gifted 174 shares and bought $7,915 worth of shares (116 units at $68.23), decreasing direct ownership by 3% to 29,007 units (SEC Form 4)

    4 - TJX COMPANIES INC /DE/ (0000109198) (Issuer)

    2/3/26 7:00:03 PM ET
    $TJX
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Aktis Oncology with a new price target

    Analyst initiated coverage of Aktis Oncology with a rating of Overweight and set a new price target of $30.00

    2/3/26 6:54:43 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities initiated coverage on Aktis Oncology with a new price target

    BofA Securities initiated coverage of Aktis Oncology with a rating of Buy and set a new price target of $34.00

    2/3/26 6:54:33 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leerink Partners initiated coverage on Aktis Oncology with a new price target

    Leerink Partners initiated coverage of Aktis Oncology with a rating of Outperform and set a new price target of $31.00

    2/3/26 6:54:33 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Leadership Updates

    Live Leadership Updates

    View All

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships

    BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Matthew McConnell, a member of the Company's Board of Directors, has joined Edible Garden's senior leadership team full time as Executive Vice President Strategic Partnerships, effective immediately. In this role, Mr. McConnell will be responsible for advancing the Company's strategic initiatives, strengthening relationships with investors and partners, and supporting long-term growth objectives across key channels.

    1/9/26 7:30:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

    January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is delighted to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary along with her election to the Board of Directors of the Company with immediate effect. Ms Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistentl

    1/5/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Oragenics Inc.

    SC 13G/A - ORAGENICS INC (0001174940) (Subject)

    11/14/24 7:29:57 PM ET
    $OGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $AKTS
    $BDRX
    $BNED
    $EDBL
    Financials

    Live finance-specific insights

    View All

    The TJX Companies, Inc. Announces Quarterly Common Stock Dividend

    The TJX Companies, Inc. (NYSE:TJX) today announced the declaration of a quarterly dividend on its common stock of $.425 per share payable March 5, 2026, to shareholders of record on February 12, 2026. About The TJX Companies, Inc. The TJX Companies, Inc., a Fortune 100 company, is the leading off-price retailer of apparel and home fashions in the U.S. and worldwide. Our mission is to deliver great value to customers every day. We do this by offering a rapidly changing assortment of quality, fashionable, brand name, and designer merchandise at prices generally 20% to 60% below full-price retailers' regular prices on comparable merchandise. We operate over 5,100 stores across nine countries

    12/9/25 3:35:00 PM ET
    $TJX
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Petco Reports Third Quarter 2025 Financial Results

    Upwardly Revises Fiscal 2025 Earnings Outlook* SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced its third quarter 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Q3 2025 Overview Net sales of $1.5 billion decreased 3.1% year over year in line with the company's third quarter outlookComparable sales decreased 2.2% year over yearGross profit margin expanded approximately 75 ba

    11/25/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    The TJX Companies, Inc. Reports Q3 FY26 Results; Comp Sales Growth of 5%, Pretax Profit Margin of 12.7%, and Diluted EPS of $1.28 All Well Above Plan; Increases FY26 Comp Sales Growth, Pretax Profit Margin, and EPS Guidance

    Q3 consolidated comparable sales increased 5%, well above the Company's plan Q3 pretax profit margin of 12.7%, well above the Company's plan Q3 diluted earnings per share of $1.28, up 12% and well above the Company's plan Returned $1.1 billion to shareholders in Q3 through share repurchases and dividends Increases full year FY26 comp sales growth, pretax profit margin, and diluted earnings per share guidance The TJX Companies, Inc. (NYSE:TJX), the leading off-price apparel and home fashions retailer in the U.S. and worldwide, today announced sales and operating results for the third quarter ended November 1, 2025. Net sales for the third quarter of Fiscal 2026 were $15.1 bil

    11/19/25 7:30:00 AM ET
    $TJX
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary